Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 085121

Expand all

MEPERIDINE AND ATROPINE SULFATE (ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE)
0.4MG/ML;50MG/ML
Marketing Status: Discontinued

Active Ingredient: ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
Proprietary Name: MEPERIDINE AND ATROPINE SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.4MG/ML;50MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A085121
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

MEPERIDINE AND ATROPINE SULFATE (ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE)
0.4MG/ML;75MG/ML
Marketing Status: Discontinued

Active Ingredient: ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
Proprietary Name: MEPERIDINE AND ATROPINE SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.4MG/ML;75MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A085121
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

MEPERIDINE AND ATROPINE SULFATE (ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE)
0.4MG/ML;100MG/ML
Marketing Status: Discontinued

Active Ingredient: ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
Proprietary Name: MEPERIDINE AND ATROPINE SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 0.4MG/ML;100MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A085121
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information